Summary & Overview
CPT 78195: Lymphatic and Lymph Node Scintigraphy
CPT code 78195 denotes a nuclear medicine diagnostic procedure that employs a gamma–emitting radioactive tracer to image and localize disease within the lymphatics and lymph nodes. Nationally, this code is used in evaluation of lymphatic mapping, sentinel node identification, and detection of lymphatic obstruction or metastatic involvement, making it important for oncology staging and surgical planning. Key payers considered include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Readers will learn the clinical context and typical sites of service for CPT code 78195, common billing considerations, and payer coverage patterns. The publication provides benchmarks and coding guidance relevant to radiology and nuclear medicine service lines, and summarizes how payers commonly handle authorization and reimbursement for lymphatic scintigraphy. It also highlights areas where policy updates or payer-specific rules can affect utilization and claim adjudication. Data not available in the input for specific payer policies, associated taxonomies, and ICD-10 diagnoses are noted as unavailable where applicable.
Billing Code Overview
CPT code 78195 describes a nuclear medicine procedure in which a provider uses a gamma–emitting radioactive tracer to diagnose and localize diseases of the lymphatics and lymph nodes. This procedure is a form of lymphatic and lymph node scintigraphy used to visualize lymphatic drainage patterns and identify sentinel or abnormal lymph nodes.
-
Service type: Diagnostic nuclear medicine imaging using a gamma–emitting tracer
-
Typical site of service: Outpatient imaging center, hospital radiology or nuclear medicine department
Clinical & Coding Specifications
Clinical Context
A typical patient is a 55-year-old female with newly diagnosed cutaneous melanoma on the lower leg scheduled for sentinel lymph node mapping prior to wide local excision. The nuclear medicine team administers a gamma-emitting radiotracer (technetium-99m sulfur colloid) via intradermal injections around the primary lesion in preoperative holding. Dynamic and static lymphoscintigraphy images are acquired to identify the sentinel lymph node basin. The nuclear medicine physician marks the skin overlying the hottest node and provides a report documenting tracer injection sites, lymphatic drainage pattern, and location of sentinel nodes. The surgical team uses the localization information intraoperatively with a handheld gamma probe to guide sentinel lymph node biopsy. Typical workflow steps: preauthorization and scheduling; patient check-in and consent; radiotracer preparation and injection; imaging acquisition (planar/dynamic); image interpretation and skin marking; postoperative reporting and coordination with surgical scheduling.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when billing only the physician interpretation/reporting of the imaging study separate from technical imaging services. |
TC |